We are live on
!
Find out more
EIM
Essex Investment Management Portfolio holdings
AUM
$632M
1-Year Est. Return
95.36%
This Fund
S&P 500
This Quarter
Est. Return
+16.88%
1 Year Est. Return
+95.36%
3 Year Est. Return
+271.62%
5 Year Est. Return
+354.98%
10 Year Est. Return
+3,586.14%
AUM
$820M
AUM Growth
+$14.5M
(+1.8%)
Cap. Flow
-$58.3M
Cap. Flow
% of AUM
-7.11%
Top 10 Holdings %
Top 10 Hldgs %
15.04%
Holding
537
New
56
Increased
73
Reduced
203
Closed
92
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AT&T
T
|
+$6.12M |
| 2 |
CRISPR Therapeutics
CRSP
|
+$5.37M |
| 3 |
Sensata Technologies
ST
|
+$5.01M |
| 4 |
DarioHealth
DRIO
|
+$3.05M |
| 5 |
TWTR
Twitter, Inc.
TWTR
|
+$3.05M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teladoc Health
TDOC
|
+$8.61M |
| 2 |
SPWR
SunPower Corporation Common Stock
SPWR
|
+$6.72M |
| 3 |
VeriSign
VRSN
|
+$5.32M |
| 4 |
BioLife Solutions
BLFS
|
+$4.9M |
| 5 |
Fulgent Genetics
FLGT
|
+$4.74M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.55% |
| 2 | Healthcare | 17.09% |
| 3 | Industrials | 12.67% |
| 4 | Materials | 10.49% |
| 5 | Consumer Discretionary | 9.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
X
201
DELISTED
US Steel
X
| $1.31M | 0.16% |
+50,000
| New | +$987K |
|
202
Ceco Environmental
CECO
$4.58B
| $1.3M | 0.16% |
164,547
-17,336
| -10% | -$137K |
|
203
United Airlines
UAL
$41.2B
| $1.3M | 0.16% |
22,646
-41,354
| -65% | -$2.02M |
|
|
SCTL
204
DELISTED
Societal CDMO, Inc. Common Stock
SCTL
| $1.3M | 0.16% |
466,992
+367,946
| +371% | +$1.32M |
|
205
Skyworks Solutions
SWKS
$10.4B
| $1.3M | 0.16% |
7,090
-484
| -6% | -$84.1K |
|
206
Stereotaxis
STXS
$138M
| $1.29M | 0.16% |
191,965
-20,755
| -10% | -$123K |
|
207
OptimizeRx
OPRX
$149M
| $1.28M | 0.16% |
+26,322
| New | +$1.27M |
|
208
Qualcomm
QCOM
$173B
| $1.28M | 0.16% |
9,647
-1,003
| -9% | -$145K |
|
209
Roku
ROKU
$22.7B
| $1.26M | 0.15% |
3,873
-403
| -9% | -$158K |
|
|
CLDR
210
DELISTED
Cloudera, Inc.
CLDR
| $1.26M | 0.15% |
103,711
-1,884
| -2% | -$28.1K |
|
|
211
Fulgent Genetics
FLGT
$514M
| $1.25M | 0.15% |
12,934
-45,886
| -78% | -$4.74M |
|
212
Norwegian Cruise Line
NCLH
$8.82B
| $1.25M | 0.15% |
+45,292
| New | +$1.21M |
|
213
Genasys
GNSS
$77M
| $1.23M | 0.15% |
184,259
| – | – |
|
214
Novavax
NVAX
$1.34B
| $1.23M | 0.15% |
+6,794
| New | +$1.35M |
|
|
VNTR
215
DELISTED
Venator Materials PLC
VNTR
| $1.22M | 0.15% |
+263,800
| New | +$1.12M |
|
216
AeroVironment
AVAV
$9.47B
| $1.22M | 0.15% |
+10,508
| New | +$1.23M |
|
217
PENN Entertainment
PENN
$2.54B
| $1.22M | 0.15% |
+11,619
| New | +$1.29M |
|
218
Clean Harbors
CLH
$16.8B
| $1.17M | 0.14% |
13,946
+10,870
| +353% | +$914K |
|
|
VERO
219
DELISTED
Venus Concept
VERO
| $1.17M | 0.14% |
+3,020
| New | +$1.2M |
|
220
Nike
NKE
$60.4B
| $1.14M | 0.14% |
8,540
-641
| -7% | -$89.1K |
|
221
Independent Bank
INDB
$4.06B
| $1.13M | 0.14% |
+13,400
| New | +$1.12M |
|
|
BHVN
222
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $1.13M | 0.14% |
+16,485
| New | +$1.33M |
|
223
Primoris Services
PRIM
$4.32B
| $1.13M | 0.14% |
33,992
-1,433
| -4% | -$47.2K |
|
224
PayPal
PYPL
$50.9B
| $1.12M | 0.14% |
4,620
+1,386
| +43% | +$350K |
|
225
Snap-on
SNA
$20.9B
| $1.08M | 0.13% |
4,699
| – | – |
|
Similar funds
BI
KCMH
SFM
VIM
AP
TTSTC
WCM
FTC
Essex Investment Management's Q1 2021 Portfolio in Review
As of Q1 2021, Essex Investment Management held 537 positions worth $820M, up 1.8% from $806M the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Essex Investment Management withdrew a net $58.3M in Q1 2021, closing 92 positions and reducing 203 holdings. Its most notable exit was VeriSign, an estimated $5.32M position sold in full.
By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 27% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, Essex Investment Management opened a new position in CRISPR Therapeutics worth $4.33M.
- Essex Investment Management's largest Q1 2021 buy was CRISPR Therapeutics: 35,540 shares worth $4.33M.
- Essex Investment Management added most to AT&T in Q1 2021, an estimated $6.12M increase.
- Essex Investment Management's biggest Q1 2021 reduction was Teladoc Health, cutting an estimated $8.61M.
- Essex Investment Management fully exited VeriSign in Q1 2021, selling an estimated $5.32M.
- Essex Investment Management's ten largest holdings make up 15% of its $820M portfolio in Q1 2021.
- Essex Investment Management opened 56 new positions and closed 92 in Q1 2021.
- Essex Investment Management's portfolio value rose 1.8% quarter-over-quarter to $820M.
Based on Essex Investment Management's 13F filing for Q1 2021, filed 12 May 2021.